• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

异柠檬酸脱氢酶1(IDH1)R132H突变对能量代谢的影响:组织与相应原发性胶质瘤细胞培养物的比较

Effects of the IDH1 R132H Mutation on the Energy Metabolism: A Comparison between Tissue and Corresponding Primary Glioma Cell Cultures.

作者信息

Dekker Lennard J M, Verheul Cassandra, Wensveen Nicky, Leenders William, Lamfers Martine L M, Leenstra Sieger, Luider Theo M

机构信息

Laboratories of Neuro-Oncology/Clinical and Cancer Proteomics, Department of Neurology, Erasmus MC, Rotterdam, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands.

Department of Neurosurgery, Erasmus MC, Rotterdam, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands.

出版信息

ACS Omega. 2022 Jan 19;7(4):3568-3578. doi: 10.1021/acsomega.1c06121. eCollection 2022 Feb 1.

DOI:10.1021/acsomega.1c06121
PMID:35128264
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8811756/
Abstract

The R132H mutation in the metabolic enzyme isocitrate dehydrogenase 1 (IDH1) is the most important prognostic factor for the survival of glioma patients. Subsequent studies led to the discovery of a panel of enzymes mainly involved in glutamate anaplerosis and aerobic glycolysis that change in abundance as a result of the mutation. To further study these changes, appropriate glioma models are required that accurately mimic metabolism. To investigate how metabolism is affected by cell culture, we here compared surgically obtained snap-frozen glioma tissues with their corresponding primary glioma cell culture models with a previously developed targeted mass spectrometry proteomic assay. We determined the relative abundance of a panel of metabolic enzymes. Results confirmed increased glutamate use and decreased aerobic glycolysis in resected IDH1 R132H glioma tissue samples. However, these metabolic profiles were not reflected in the paired glioma primary cell cultures. We suggest that culture conditions and tumor microenvironment play a crucial role in maintaining the metabolic situation in cell culture models. For this reason, new models that more closely resemble the microenvironment, such as three-dimensional cell co-cultures or organotypic multicellular spheroid models, need to be developed and investigated.

摘要

代谢酶异柠檬酸脱氢酶1(IDH1)中的R132H突变是胶质瘤患者生存的最重要预后因素。随后的研究发现了一组主要参与谷氨酸回补和有氧糖酵解的酶,它们的丰度因该突变而发生变化。为了进一步研究这些变化,需要合适的胶质瘤模型来准确模拟代谢。为了研究细胞培养如何影响代谢,我们在此使用先前开发的靶向质谱蛋白质组学分析方法,将手术获取的速冻胶质瘤组织与其相应的原发性胶质瘤细胞培养模型进行了比较。我们测定了一组代谢酶的相对丰度。结果证实,在切除的IDH1 R132H胶质瘤组织样本中,谷氨酸的利用增加,有氧糖酵解减少。然而,这些代谢特征在配对的胶质瘤原代细胞培养中并未体现。我们认为培养条件和肿瘤微环境在维持细胞培养模型中的代谢状况方面起着关键作用。因此,需要开发和研究更接近微环境的新模型,如三维细胞共培养或器官型多细胞球体模型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22dc/8811756/70a8ef4bf6d5/ao1c06121_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22dc/8811756/66fd5ea65ad0/ao1c06121_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22dc/8811756/b5564973f324/ao1c06121_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22dc/8811756/7d57b75c0ff5/ao1c06121_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22dc/8811756/70a8ef4bf6d5/ao1c06121_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22dc/8811756/66fd5ea65ad0/ao1c06121_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22dc/8811756/b5564973f324/ao1c06121_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22dc/8811756/7d57b75c0ff5/ao1c06121_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22dc/8811756/70a8ef4bf6d5/ao1c06121_0005.jpg

相似文献

1
Effects of the IDH1 R132H Mutation on the Energy Metabolism: A Comparison between Tissue and Corresponding Primary Glioma Cell Cultures.异柠檬酸脱氢酶1(IDH1)R132H突变对能量代谢的影响:组织与相应原发性胶质瘤细胞培养物的比较
ACS Omega. 2022 Jan 19;7(4):3568-3578. doi: 10.1021/acsomega.1c06121. eCollection 2022 Feb 1.
2
Extracellular glutamate and IDH1 inhibitor promote glioma growth by boosting redox potential.细胞外谷氨酸和 IDH1 抑制剂通过提高氧化还原电势促进胶质瘤生长。
J Neurooncol. 2020 Feb;146(3):427-437. doi: 10.1007/s11060-019-03359-w. Epub 2020 Feb 4.
3
IDH1(R132H) mutation causes a less aggressive phenotype and radiosensitizes human malignant glioma cells independent of the oxygenation status.IDH1(R132H) 突变导致侵袭性降低,并独立于氧合状态使人类恶性神经胶质瘤细胞对放疗增敏。
Radiother Oncol. 2015 Sep;116(3):381-7. doi: 10.1016/j.radonc.2015.08.007. Epub 2015 Aug 29.
4
Metabolic changes related to the IDH1 mutation in gliomas preserve TCA-cycle activity: An investigation at the protein level.与胶质瘤 IDH1 突变相关的代谢变化可维持 TCA 循环活性:在蛋白质水平上的研究。
FASEB J. 2020 Mar;34(3):3646-3657. doi: 10.1096/fj.201902352R. Epub 2020 Jan 20.
5
Monoallelic IDH1 R132H Mutation Mediates Glioma Cell Response to Anticancer Therapies via Induction of Senescence.单等位基因 IDH1 R132H 突变通过诱导衰老介导胶质细胞瘤细胞对癌症治疗的反应。
Mol Cancer Res. 2021 Nov;19(11):1878-1888. doi: 10.1158/1541-7786.MCR-21-0284. Epub 2021 Aug 4.
6
R132H mutation in IDH1 gene reduces proliferation, cell survival and invasion of human glioma by downregulating Wnt/β-catenin signaling.异柠檬酸脱氢酶1(IDH1)基因中的R132H突变通过下调Wnt/β-连环蛋白信号传导来降低人胶质瘤的增殖、细胞存活和侵袭能力。
Int J Biochem Cell Biol. 2016 Apr;73:72-81. doi: 10.1016/j.biocel.2016.02.007. Epub 2016 Feb 6.
7
In silico gene expression analysis reveals glycolysis and acetate anaplerosis in IDH1 wild-type glioma and lactate and glutamate anaplerosis in IDH1-mutated glioma.计算机模拟基因表达分析揭示了异柠檬酸脱氢酶1(IDH1)野生型胶质瘤中的糖酵解和乙酸盐回补途径,以及IDH1突变型胶质瘤中的乳酸和谷氨酸回补途径。
Oncotarget. 2017 Jul 25;8(30):49165-49177. doi: 10.18632/oncotarget.17106.
8
IDH1 is intrinsically tumor-suppressive but functionally attenuated by the glutamate-rich cerebral environment.异柠檬酸脱氢酶1(IDH1)本质上具有肿瘤抑制作用,但在富含谷氨酸的脑环境中其功能会减弱。
Oncotarget. 2018 Oct 12;9(80):35100-35113. doi: 10.18632/oncotarget.26203.
9
Overexpression of isocitrate dehydrogenase mutant proteins renders glioma cells more sensitive to radiation.突变型异柠檬酸脱氢酶蛋白的过表达使神经胶质瘤细胞对辐射更敏感。
Neuro Oncol. 2013 Jan;15(1):57-68. doi: 10.1093/neuonc/nos261. Epub 2012 Oct 31.
10
Nanomechanical Signatures in Glioma Cells Depend on CD44 Distribution in IDH1 Wild-Type but Not in IDH1R132H Mutant Early-Passage Cultures.神经胶质瘤细胞的纳米力学特征依赖于 IDH1 野生型而非 IDH1R132H 突变早期传代培养物中 CD44 的分布。
Int J Mol Sci. 2023 Feb 17;24(4):4056. doi: 10.3390/ijms24044056.

引用本文的文献

1
Mitochondrial DNA copy number alterations: Key players in the complexity of glioblastoma (Review).线粒体DNA拷贝数改变:胶质母细胞瘤复杂性中的关键因素(综述)
Mol Med Rep. 2025 Mar;31(3). doi: 10.3892/mmr.2025.13443. Epub 2025 Jan 31.
2
Research Progress of NK Cells in Glioblastoma Treatment.自然杀伤细胞在胶质母细胞瘤治疗中的研究进展
Onco Targets Ther. 2025 Jan 18;18:87-106. doi: 10.2147/OTT.S486411. eCollection 2025.
3
Bioinformatic Characterization of the Functional and Structural Effect of Single Nucleotide Mutations in Patients with High-Grade Glioma.

本文引用的文献

1
Generation, characterization, and drug sensitivities of 12 patient-derived IDH1-mutant glioma cell cultures.12例患者来源的异柠檬酸脱氢酶1(IDH1)突变型胶质瘤细胞培养物的生成、特性鉴定及药敏性
Neurooncol Adv. 2021 Aug 2;3(1):vdab103. doi: 10.1093/noajnl/vdab103. eCollection 2021 Jan-Dec.
2
Role of glioblastoma stem cells in cancer therapeutic resistance: a perspective on antineoplastic agents from natural sources and chemical derivatives.胶质母细胞瘤干细胞在癌症治疗耐药中的作用:从天然来源和化学衍生物的抗肿瘤药物角度看。
Stem Cell Res Ther. 2021 Mar 24;12(1):206. doi: 10.1186/s13287-021-02231-x.
3
Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology.
高级别胶质瘤患者单核苷酸突变功能和结构效应的生物信息学特征分析
Biomedicines. 2024 Oct 9;12(10):2287. doi: 10.3390/biomedicines12102287.
4
Non-Invasive Assessment of Isocitrate Dehydrogenase-Mutant Gliomas Using Optimized Proton Magnetic Resonance Spectroscopy on a Routine Clinical 3-Tesla MRI.在常规临床3特斯拉磁共振成像上使用优化的质子磁共振波谱对异柠檬酸脱氢酶突变型胶质瘤进行无创评估
Cancers (Basel). 2023 Sep 7;15(18):4453. doi: 10.3390/cancers15184453.
5
Metabolic partitioning in the brain and its hijacking by glioblastoma.大脑中的代谢分割及其被胶质母细胞瘤劫持。
Genes Dev. 2023 Aug 1;37(15-16):681-702. doi: 10.1101/gad.350693.123. Epub 2023 Aug 30.
6
Regulative Roles of Metabolic Plasticity Caused by Mitochondrial Oxidative Phosphorylation and Glycolysis on the Initiation and Progression of Tumorigenesis.线粒体氧化磷酸化和糖酵解引起的代谢可塑性在肿瘤发生的起始和进展中的调节作用。
Int J Mol Sci. 2023 Apr 11;24(8):7076. doi: 10.3390/ijms24087076.
7
U3 snoRNA-mediated degradation of ZBTB7A regulates aerobic glycolysis in isocitrate dehydrogenase 1 wild-type glioblastoma cells.U3 snoRNA 通过调控 ZBTB7A 的降解来调节 IDH1 野生型脑胶质瘤细胞的有氧糖酵解。
CNS Neurosci Ther. 2023 Oct;29(10):2811-2825. doi: 10.1111/cns.14218. Epub 2023 Apr 17.
8
Ferroptosis: A novel therapeutic strategy and mechanism of action in glioma.铁死亡:一种胶质瘤治疗的新策略及作用机制
Front Oncol. 2022 Sep 15;12:947530. doi: 10.3389/fonc.2022.947530. eCollection 2022.
患者来源的类器官和原发及复发性脑胶质瘤的原位异种移植为精准肿瘤学提供了相关的患者替身。
Acta Neuropathol. 2020 Dec;140(6):919-949. doi: 10.1007/s00401-020-02226-7. Epub 2020 Oct 3.
4
Patient-derived cells from recurrent tumors that model the evolution of -mutant glioma.来自复发性肿瘤的患者源细胞,可模拟突变型胶质瘤的演变。
Neurooncol Adv. 2020 Jul 16;2(1):vdaa088. doi: 10.1093/noajnl/vdaa088. eCollection 2020 Jan-Dec.
5
Metabolic changes related to the IDH1 mutation in gliomas preserve TCA-cycle activity: An investigation at the protein level.与胶质瘤 IDH1 突变相关的代谢变化可维持 TCA 循环活性:在蛋白质水平上的研究。
FASEB J. 2020 Mar;34(3):3646-3657. doi: 10.1096/fj.201902352R. Epub 2020 Jan 20.
6
A Patient-Derived Glioblastoma Organoid Model and Biobank Recapitulates Inter- and Intra-tumoral Heterogeneity.患者来源的脑胶质瘤类器官模型和生物库再现了肿瘤内和肿瘤间的异质性。
Cell. 2020 Jan 9;180(1):188-204.e22. doi: 10.1016/j.cell.2019.11.036. Epub 2019 Dec 26.
7
-mutated cancers are sensitive to the green tea polyphenol epigallocatechin-3-gallate.突变癌症对绿茶多酚表没食子儿茶素-3-没食子酸酯敏感。
Cancer Metab. 2019 May 20;7:4. doi: 10.1186/s40170-019-0198-7. eCollection 2019.
8
Glioblastoma heterogeneity and the tumour microenvironment: implications for preclinical research and development of new treatments.胶质母细胞瘤异质性和肿瘤微环境:对临床前研究和新疗法开发的影响。
Biochem Soc Trans. 2019 Apr 30;47(2):625-638. doi: 10.1042/BST20180444. Epub 2019 Mar 22.
9
Neoantigens in Chronic Obstructive Pulmonary Disease and Lung Cancer: A Point of View.慢性阻塞性肺疾病和肺癌中的新抗原:观点。
Proteomics Clin Appl. 2019 Mar;13(2):e1800093. doi: 10.1002/prca.201800093. Epub 2019 Feb 11.
10
Improving the metabolic fidelity of cancer models with a physiological cell culture medium.用生理细胞培养液提高癌症模型的代谢保真度。
Sci Adv. 2019 Jan 2;5(1):eaau7314. doi: 10.1126/sciadv.aau7314. eCollection 2019 Jan.